Niki BioSolutions, Inc. (NIKI) Interest Expenses (2017 - 2025)

Niki BioSolutions (NIKI) has 9 years of Interest Expenses data on file, last reported at $84502.0 in Q4 2025.

• Quarterly Interest Expenses rose 352.54% year-over-year to $84502.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $123341.0 (up 217.57% YoY) and the FY2025 annual result came in at $16.0 million, up 1.37% from the prior year.
• Interest Expenses eased to $84502.0 in Q4 2025, from $250000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $17.4 million in Q4 2023 to a low of $8076.0 in Q2 2023.
• A 5-year average of $4.0 million and a median of $336705.5 in 2021 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses sank 89.26% — and 2025, when it surged 1139.71%.
• Tracing NIKI's Interest Expenses over 5 years: stood at $12.6 million in 2021, then gained by 24.33% to $15.7 million in 2022, then advanced by 10.84% to $17.4 million in 2023, then slumped by 99.89% to $18673.0 in 2024, then jumped by 352.54% to $84502.0 in 2025.
• The last three Interest Expenses figures came in at $84502.0 (Q4 2025), $250000.0 (Q3 2025), and $848338.0 (Q2 2025), per Business Quant data.